Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.
作者:
主题词
投药, 口服(Administration, Oral);成年人(Adult);抗病毒药(Antiviral Agents);曲线下面积(Area Under Curve);巨细胞病毒感染(Cytomegalovirus Infections);双盲法(Double-Blind Method);女(雌)性(Female);更昔洛韦(Ganciclovir);移植物排斥(Graft Rejection);移植物存活(Graft Survival);人类(Humans);男(雄)性(Male);中年人(Middle Aged);器官移植(Organ Transplantation);手术后并发症(Postoperative Complications);前瞻性研究(Prospective Studies);时间因素(Time Factors)
DOI
10.1111/j.1600-6143.2004.00382.x
PMID
15023154
发布时间
2023-01-24
- 浏览46
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文